Alnylam Act

Alnylam Act

Alnylam is sponsoring free, third-party genetic testing and counseling for individuals who may carry a gene mutation known to be associated with hereditary ATTR (hATTR) amyloidosis. The Alnylam Act™ (formerly known as Alnylam Assist) program was created to potentially increase diagnosis rates and to provide genetic counseling to help people make more informed decisions about their health.

Learn More.



SIGN UP FOR PATIENT CONNECT

Receive updates on our investigational therapies and clinical trials.